SPRY

ARS Pharmaceuticals, Inc.

8.70 USD
-0.01 (-0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ARS Pharmaceuticals, Inc. stock is up 37.01% since 30 days ago. The next earnings date is Aug 29, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 March’s closed higher than February. In the last 5 Unusual Options Trades, there were 4 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Jan 20:13 19 Apr, 2024 5.00 CALL 250 0
22 Jan 18:06 21 Jun, 2024 5.00 PUT 236 568
23 Jan 16:03 15 Mar, 2024 2.50 CALL 100 1178
24 Jan 15:32 15 Mar, 2024 2.50 CALL 200 1455
29 Feb 19:04 15 Mar, 2024 2.50 CALL 200 1608

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.